VTYX•prnewswire•
Shareholder Alert: The Ademi Firm investigates whether Ventyx Biosciences, Inc. is obtaining a Fair Price for its Public Shareholders
Summary
MILWAUKEE, Jan. 7, 2026 /PRNewswire/ -- Ademi LLP is investigating Ventyx (NASDAQ: VTYX) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Eli Lilly. Click here to learn how to join our investigation and obtain additional...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 8, 2026 by prnewswire